Format

Send to

Choose Destination
Scand J Infect Dis. 1995;27(3):241-3.

Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome.

Author information

1
Department of Pediatrics, Ondokuz Mayis University School of Medicine, Samsun, Turkey.

Abstract

Guillain-Barre syndrome is an acquired demyelinating polyneuropathy that is presumed to be immune-mediated. On the basis of this assumption, intravenous immunoglobulin (IVIG) has been used in the treatment of Guillain-Barre syndrome in recent years and found to be effective. To test this we performed a randomized study in patients with Guillain-Barre syndrome by giving IVIG (1 g/kg body weight per day over 2 consecutive days) in 9 children who were compared with 9 patients who were observed but not given specific therapy. We concluded that intravenous immunoglobulin is a safe and effective treatment for childhood Guillain-Barre syndrome which shortens the time to recovery.

PMID:
8539548
DOI:
10.3109/00365549509019016
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center